Posts filtered by tags: Gilead Sciences[x]


 

The US is sprinting to develop a coronavirus vaccine or treatment. Here's how 19 top drugmakers are racing to tackle the pandemic.

In attempting to counter the coronavirus pandemic, leading drugmakers are researching treatments and vaccines to stop the virus. The small biotech Moderna has leaped to the front of the race, with a vaccine candidate that's being tested in people. Pharma giants like Johnson & Johnson and Sanofi are also in the early stages of developing potential vaccines. There's no assurance the vaccines will work. It will take at least 12 months to 18 months to determine if these experimental vaccines are s...
Tags: Japan, Elon Musk, New York, Microsoft, California, Washington, China, Boston, Massachusetts, US, San Francisco, Trends, Georgia, Indianapolis, Pennsylvania, Bill Gates


Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More

Finding and enrolling patients for clinical trials is always challenging. The coronavirus pandemic has made it nearly impossible.Fallout from the spread of COVID-19 infections led several companies to declare this week that they would stop enrolling patients in clinical trials or postpone studies that have not yet started. Eli Lilly (NYSE: LLY) said that many healthcare systems are devoting their resources to treating COVID-19 patients, which makes it difficult for these sites to also start new...
Tags: Deals, Startups, Ipo, Trends, Investing, It, Software, Insomnia, Multiple Sclerosis, Astrazeneca, Fda, National, Type 2 Diabetes, Epilepsy, Pfizer, Parkinson's Disease


Fact check: Drugmaker Gilead Sciences claimed rights to a possible COVID-19 treatment

Gilead Sciences received special FDA protection for the antiviral drug remdesivir. Facing criticism, it withdrew its request for "orphan status."
Tags: Science, Fda, Gilead Sciences


Pharma Giant Gilead Retracts Request FDA Extend Monopoly Status on Experimental Covid-19 Drug

Pharmaceutical giant Gilead Sciences on Wednesday retracted its effort to score extended monopoly rights and tax breaks on its antiviral drug remdesivir, which scientists are evaluating as a possible treatment in the novel coronavirus pandemic.Read more...
Tags: Health, Science, Pharmaceuticals, Gilead Sciences, Big Pharma, Gilead, Coronavirus, Covid 19, Sars Cov 2, Remdesivir, Pharma Giant Gilead


The US is sprinting to develop a coronavirus vaccine or treatment. Here's how 12 top drugmakers are racing to tackle the pandemic.

In attempting to counter the coronavirus pandemic, leading drugmakers are researching treatments and vaccines to stop the virus. The small biotech Moderna has leaped to the front of the race, with its vaccine candidate ready to begin testing in people. Pharma giants like Johnson & Johnson and Sanofi are also in the early stages of developing potential vaccines. There's no assurance the vaccines will work. It will take at least 12 months to 18 months to determine if these experimental vaccines ...
Tags: South Korea, Japan, Elon Musk, New York, California, Washington, White House, China, US, San Francisco, Trends, Indianapolis, Pennsylvania, Who, World Health Organization, Fda


FDA Urges Caution After Trump Says Malaria Drug Will Be Available to Coronavirus Patients ‘Almost Immediately’

An anti-malaria drug has been approved for use in treating coronavirus symptoms, President Trump said Thursday—however officials immediately cautioned that approval for widespread use was still a long way off.The drug Hydroxychloroquine, used on malaria and arthritis patients, will be made available “almost immediately” to coronavirus patients with a prescription, Trump said during the administration’s coronavirus task force briefing on Thursday. The U.S. Food and Drug Administration has slashed...
Tags: News, Washington Post, White House, Bloomberg, Fda, Associated Press, State Department, The Daily Beast, Ucla, Trump, Mike Pence, U S Food and Drug Administration, Gilead Sciences, Gilead, Hahn, One America News Network


Japanese flu drug appears ‘effective’ in coronavirus treatment in Chinese clinical trials

Japanese-made flu drug favipiravir (also known as Avigan) has been shown to be effective in both reducing the duration of the COVID-19 virus in patients, and to have improved the lung conditions of those who received treatment with the drug, based on results of clinical trials conducted with affected patients in both Wuhan and Shenzhen by Chinese medical authorities. The trials involved 340 patients in total, and since they drug has already been developed and approved for use in treating flu, it...
Tags: Health, TC, Ebola, Science, Medicine, China, Tech, The Guardian, Flu, Wuhan, Shenzhen, Gilead Sciences, Avigan, Coronavirus, COVID-19, Remdesivir


Facebook just named two women to its board as it seeks gender parity — here are 13 tech companies that have recently diversified their boardrooms (FB)

Facebook went public with an all-male board, but nearly achieved gender parity last week when it added two women directors. The announcement came as companies face growing pressure from employees, customers, investors, and lawmakers to increase diversity within their ranks, especially among upper leadership. While the tech industry has moved slow so far, companies like Alphabet, Amazon, Airbnb, and HP are at least making some progress in the boardroom. Here are 13 tech companies that have adde...
Tags: Apple, Google, Facebook, California, US, San Francisco, Trends, Paypal, Autodesk, Starbucks, Deloitte, National Basketball Association, Kpmg, Tivo, Sundar Pichai, Polycom


First human trial for coronavirus vaccine begins

U.S. health officials confirmed on Monday the first human trial testing a potential vaccine to prevent COVID-19, the disease caused by the new coronavirus. Read about the coronavirus vaccine clinical trial at the NIH website. The National Institutes of Health (NIH), a federal agency within the Department of Health and Human Services, has been fast-tracking work with biotech company Moderna to develop a vaccine using the current strain of the new coronavirus, reports CNBC: The trial is takin...
Tags: Post, News, Cdc, Washington, US, US news, Ap, Public Health, Anthony Fauci, Nih, Cnbc, Gilead Sciences, Department of Health and Human Services, Seattle Washington, The National Institutes of Health NIH, Pandemic


Four Ways Experts Say Coronavirus Nightmare Could End

As major cultural events are forgotten, workplaces, bars, and restaurants close, and prominent politicians across the world go into quarantine, two simple questions about the novel coronavirus pandemic seem to rise above the rest: How long will this last? And how will it end?Dr. William Haseltine, president of the global health think tank ACCESS Health International who recently chaired the U.S.-China Health Summit in Wuhan, where the virus likely originated, has a theory.“There are four ways,” ...
Tags: South Korea, Japan, New York, News, Cdc, China, New York City, Los Angeles, United States, Broadway, Food And Drug Administration, World Health Organization, Fda, Andrew Cuomo, Anthony Fauci, Wuhan


The US is sprinting to develop a coronavirus vaccine or treatment. Here's how 10 top drugmakers are racing to tackle the pandemic.

As the coronavirus outbreak has progressed into a pandemic, leading drugmakers are researching treatments and vaccines to stop the virus. The small biotech Moderna has leaped to the front of the race, with its vaccine candidate ready to begin testing in people. Pharma giants like Johnson & Johnson and Sanofi are also in the early stages of developing potential vaccines. There's no assurance the vaccines will work. It will take at least 12 months to 18 months to determine if these experimental ...
Tags: South Korea, Japan, New York, California, Washington, White House, China, Massachusetts, US, San Francisco, Trends, Indianapolis, Pennsylvania, Who, World Health Organization, National Institutes of Health


Kymera Closes $102M Round to Bring Protein-Busting Drugs to the Clinic

Reuse and recycle is more than an environmental slogan. It’s also a succinct description of how cells deal with old or damaged proteins. Kymera Therapeutics is developing drugs that use this cyclical cellular process to treat disease, and it has raised $102 million to move into clinical testing next year.The Series C round of funding was led by Biotechnology Value Fund and Redmile Group.The cellular process of breaking down proteins for reuse is called protein degradation. This system works by ...
Tags: Deals, Startups, Boston, Cancer, Trends, Investing, GlaxoSmithKline, Pfizer, Biotech, Immunology, Blackrock, Life Sciences, Bayer, Autoimmune Diseases, Genentech, Gilead Sciences


The US is sprinting to develop a coronavirus vaccine or treatment. Here's how 9 top drugmakers are racing to tackle the pandemic.

As the coronavirus outbreak has progressed into a pandemic, leading drugmakers are researching treatments and vaccines to stop the virus. The small biotech Moderna has leaped to the front of the race, with its vaccine candidate ready to begin testing in people. Pharma giants like Johnson & Johnson and Sanofi are also in the early stages of developing potential vaccines. There's no assurance the vaccines will work. It will take at least 12 months to 18 months to determine if these experimental ...
Tags: Japan, New York, California, White House, China, US, San Francisco, Trends, Pennsylvania, Who, World Health Organization, National Institutes of Health, Pfizer, Pharma, Anthony Fauci, Nih


How coronavirus is upending corporate America

Hello! There's really only one business story in the world right now, and that's coronavirus. Here's what you need to now: How hospitals are preparing  Hospitals are bracing for what could be millions of admissions nationwide as the virus spreads, Lydia Ramsey reports. She writes: The American Hospital Association, which represents thousands of hospitals and health systems, hosted a webinar in February with its member hospitals and health systems. Business Insider obtained a copy of the slide...
Tags: Apple, Google, Facebook, Japan, New York, Microsoft, NYC, US, America, San Francisco, Trends, Cisco, Bank Of America, Rebecca, Switzerland, Ubs


The US is sprinting to develop a coronavirus vaccine or treatment. Here's how 9 top drugmakers are racing to tackle an outbreak that's spreading around the world.

As the coronavirus outbreak has exploded into a global public-health emergency, leading drugmakers have begun researching treatments and vaccines to stop the virus. The small biotech Moderna has leaped to the front of the race, with its vaccine candidate ready to begin testing in people. Pharma giants like Johnson & Johnson and Sanofi are also in the early stages of developing potential vaccines. There's no assurance the vaccines will work. It will take at least 12 months to 18 months to deter...
Tags: Japan, New York, California, White House, China, US, San Francisco, Trends, Pennsylvania, Who, World Health Organization, National Institutes of Health, Pfizer, Pharma, Anthony Fauci, Nih


Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More

Last month, Gilead Sciences CEO Daniel O’Day announced plans to introduce 10 “transformative medicines” over the next 10 years. Acquisitions would help meet that ambitious goal, and this week Gilead announced one of them: a nearly $5 billion deal for cancer immunotherapy developer Forty Seven.Forty Seven’s lead CD47-blocking drug—the company is named after the signaling molecule— is being tested in combination with chemotherapy as a treatment for blood cancers, although O’Day noted it could pot...
Tags: Deals, Startups, Ipo, Cancer, Trends, Venture Capital, M&a, Astrazeneca, Fda, National, Novartis, Allergan, Abbvie, Biotech, Stock Market, Nasdaq


The US is sprinting to develop a coronavirus vaccine or treatment. Here's how 7 top drugmakers are racing to tackle an outbreak that's spreading around the world.

As the coronavirus outbreak has exploded into a global public-health emergency, leading drugmakers have begun researching treatments and vaccines to stop the virus. The small biotech Moderna has leaped to the front of the race, sending a vaccine candidate to US health officials to start testing in people. Pharma giants like Johnson & Johnson and Sanofi are also in the early stages of developing potential vaccines. A vaccine would likely to take more than a year to reach mass distribution, rese...
Tags: New York, California, Washington, White House, China, Africa, US, Trends, Pennsylvania, Bill Gates, Who, World Health Organization, National Institutes of Health, GlaxoSmithKline, Pfizer, Pharma


Gilead Boosts Cancer Drug Pipeline With $4.9B Deal for Forty Seven

Gilead Sciences, which finished 2019 with nearly $26 billion at its disposal, is putting some of that money to work with a $4.9 billion deal to acquire cancer immunotherapy developer Forty Seven.Under deal terms announced Monday, Foster City, CA-based Gilead (NASDAQ: GILD) will pay $95.50 for each share of Forty Seven (NASDAQ: FTSV). That’s a more than 64 percent premium to the company’s closing stock price last Friday. When Menlo Park, CA-based Forty Seven went public in 2018, it priced its sh...
Tags: Deals, Cancer, San Francisco, Trends, Fda, Biotech, Stanford University, Chemotherapy, Life Sciences, Clinical Trials, Gilead Sciences, Menlo Park CA, Gilead, American Society of Hematology, Kite Pharma, Foster City CA


Chinese Biotech Company Censured for Claiming It Could Make Experimental Coronavirus Drug

A Chinese biotech company which claimed to be able to manufacture an experimental drug from Gilead Sciences with the potential to treat the novel coronavirus, was censured for disclosing inaccurate information. The Shanghai Stock Exchange said in an statement Sunday that BrightGene Bio-Medical Technology has not gained approval from China’s drug regulator to make the drug known as remdesivir, which is seen as the in the race to find a treatment for the virus that’s now sickened over 88,00...
Tags: News, China, Uncategorized, Bloomberg, World Health Organization, Wuhan, Gilead Sciences, Gilead, Shanghai Stock Exchange, AbbVie Inc, Bruce Aylward, Overnight, Onetime, COVID-19, Chinese Biotech Company Censured, Wang Zhengye


Dispensed: Coronavirus spreads, drugmakers scramble to respond, and the latest magic mushroom startups

Hello, Welcome to Dispensed, Business Insider's weekly healthcare newsletter. With Lydia Ramsey skiing the Colorado slopes, this week's edition is being written — for the very first time — by her colleague, Andrew Dunn. Are you new to the newsletter? You can sign up here.  And what a week for my first newsletter. Breathe in. Breathe out. Wash your hands. We've got a lot of coronavirus developments to go through, starting with speedy progress on developing a vaccine candidate.  How the buzzy b...
Tags: Colorado, California, China, US, Toronto, Trends, Fda, North America, Amgen, Gilead Sciences, Big Pharma, Lydia, Cambridge Massachusetts, Steve Jurvetson, The National Institutes of Health, Moderna


Bio Roundup: COVID-19 Trials, Esperion’s Approvals, NASH News & More

Clinical trials have historically hewn to a rigid format. A trial is designed, conducted according to that design, and then results are analyzed. Making changes in the midst of the study was a no-no.In recent years, regulators have showed openness to clinical trial designs intended to make drug testing more efficient. We’ll get to see an example play out in tests for a coronavirus infection treatment. This week, the first US clinical trial to evaluate a potential treatment for the disease enrol...
Tags: Apple, Deals, Cancer, US, Trends, Investing, Merck, It, Software, Alzheimer's Disease, Astrazeneca, Fda, National, Parkinson's Disease, Biotech, Digital Health


Drug companies race to test coronavirus vaccines

Gilead Sciences stock was up slightly on Thursday, even as the Dow plunged into correction status.
Tags: Cnn, Gilead Sciences


Stocks open sharply lower; Dow 10% below recent record high

By Damian J. Troise, The Associated Press Stocks are opening sharply lower, extending a weeklong rout and bringing the Dow Jones Industrial Average 10% below the record high it hit two weeks ago. Microsoft became the latest large company to warn investors about the virus’ potential hit to its finances. Meanwhile nations are taking increasingly drastic measures to try and contain the outbreak and the fears over the potential spread in the U.S. are rising. Bond yields continued sliding in a furthe...
Tags: South Korea, Europe, Japan, Microsoft, California, Saudi Arabia, China, Sport, Delta Airlines, Soccer, Italy, Islam, Treasury, Nasdaq, Inbev, American Airlines


The US is gearing up to test the first coronavirus treatments and vaccines. Here's how 6 top drugmakers are racing to tackle an outbreak that's spreading around the world.

As the coronavirus outbreak has exploded into a global public-health emergency, leading drugmakers have begun researching treatments and vaccines to stop the virus. The small biotech Moderna has leaped to the front of the race, sending a vaccine candidate to US health officials to start testing in people. Pharma giants like Johnson & Johnson and Sanofi are also in the early stages of advancing vaccine candidates. The National Institutes of Health is running a trial to test a drug from Gilead S...
Tags: California, China, Africa, US, Trends, Pennsylvania, Bill Gates, Middle East, World Health Organization, National Institutes of Health, GlaxoSmithKline, Pharma, Anthony Fauci, Nih, Wuhan, Cnbc


CDC Issues Warnings on Virus; Markets Take Hit: Virus Update

(Bloomberg) -- The U.S. Centers for Disease Control and Prevention warned Americans to prepare for a coronavirus outbreak at home that could lead to significant disruptions of daily life, though the warnings were downplayed by the White House. Congress was told that there’s shortage of masks needed for health workers if one occurs.New cases were reported in Europe, prompting worries of a widening outbreak there. Iran reported a total of 15 deaths, the most fatalities outside China, and a top hea...
Tags: Asia, South Korea, Europe, Japan, New York, Milan, London, News, Congress, Cdc, Washington, Senate, White House, China, Iraq, Spain


CDC Tells Americans to Start Readying for Outbreak: Virus Update

(Bloomberg) -- The U.S. Centers for Disease Control and Prevention warned Americans to prepare for a coronavirus outbreak at home that could lead to significant disruptions of daily life, though the warnings were downplayed by the White House. Congress was told that there’s shortage of masks needed for health workers if one occurs.New cases were reported in Europe, prompting worries of a widening outbreak there. Iran reported a total of 15 deaths, the most fatalities outside China, and a top hea...
Tags: Asia, South Korea, Europe, Japan, New York, Milan, London, News, Congress, Cdc, Washington, Senate, White House, China, Iraq, Spain


U.S. Short on Stockpiled Masks; Gilead Drug Trials: Virus Update

(Bloomberg) -- Iran reported a total of 15 deaths from the outbreak, the most fatalities outside China, and a top health official tested positive. Italy reported a surge in infections and Spanish police isolated 1,000 people at an island resort.The U.S. said its short on the number of masks needed for health workers in case of an outbreak. Chinese President Xi Jinping said the country was confident of limiting the impact. Earlier on Tuesday, South Korea reported 84 new infections for a total tal...
Tags: South Korea, Europe, Japan, New York, Milan, London, News, Congress, Cdc, Washington, Senate, White House, China, Iraq, Spain, Bloomberg


A buzzy biotech just outpaced the drug industry's giants to ship the first potential coronavirus vaccine. Here's how 6 top drugmakers are racing to tackle an outbreak that has already killed 2,600.

As the coronavirus outbreak has exploded into a global public-health emergency, leading drugmakers have begun researching treatments and vaccines to stop the virus. The small biotech Moderna has leaped to the front of the race, sending a vaccine candidate to US health officials to start testing in people. Pharma giants like Johnson & Johnson and Sanofi are also in the early stages of advancing vaccine candidates.  The biotech Gilead Sciences is running trials to test a drug as a treatment for ...
Tags: California, China, Africa, US, Trends, Pennsylvania, Bill Gates, Middle East, World Health Organization, National Institutes of Health, GlaxoSmithKline, Pharma, Anthony Fauci, Nih, Wuhan, Cnbc


Gilead Sciences drug remdesivir may help treat coronavirus symptoms, according to WHO

Shares of American biotech firm Gilead Sciences rose nearly 5% Monday after an official from the World Health Organization said that Gilead's drug remdesivir is showing signs that it may be able to help treat the deadly coronavirus.
Tags: Cnn, World Health Organization, Gilead Sciences, Gilead


Dow Drops More Than 1,000 as COVID-19 Outbreak Threatens Economy

The Dow Jones Industrial Average slumped more than 1,000 points Monday in the worst day for the stock market in two years as investors worry that the spread of a viral outbreak that began in China will weaken global economic growth. Traders sought safety in U.S. government bonds, gold and high-dividend stocks like utilities and real estate. The yield on the 10-year Treasury fell to the lowest level in more than three years. Technology stocks accounted for much of the broad market slide, whi...
Tags: Apple, Asia, South Korea, Europe, News, Microsoft, China, Germany, Uncategorized, Markets, Nike, Bank Of America, Italy, Middle East, Treasury, Stocks